期刊
CURRENT NEUROPHARMACOLOGY
卷 15, 期 6, 页码 926-935出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1570159X15666170116143743
关键词
Alzheimer's disease; beta amyloid; clinical trials; LTP; memory; anti-amyloid therapy
Since its discovery in 1984, the beta amyloid peptide has treaded the boards of neurosciences as the star molecule in Alzheimer's disease pathogenesis. In the last decade, however, this vision has been challenged by evidence-based medicine showing the almost complete failure of clinical trials that experimented anti-amyloid therapies with great hopes. Moreover, data have accumulated which clearly indicate that this small peptide plays a key role in the physiological processes of memory formation. In the present review, we will discuss the different aspects of the amyloid cascade hypothesis, highlighting its pros and cons, and we will analyse the results of the therapeutic approaches attempted to date that should change the direction of Alzheimer's disease research in the future.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据